ISHR-ES 2026, 39TH Annual Meeting of the International Society for Heart Research European Section. Monday 22 June - Thursday 25 June, University of Birmingham UK. Logos of the University of Birmingham and the International Society for Heart Research, European Section

Thursday 25 June 2025


Time Session/Location
 08:30 - 09:30 ISHR-INT Council Meeting - Room 202
08:30 - 09:30 Registration and Refreshments - Foyers of Teaching and Learning Building
9:30 - 10:30                         Plenary Session 4  - Lecture Theatre 1 
ECI Awards Session

A1 - Giulio Ciucci, Icgeb, Italy  
Mechanical Loading Inhibits Tumor Growth in the Heart

A2 - Thomas Wright, University College London, UK 
NLRP3 inhibition reduces myocardial infarction in the context of cardiorenal disease

A3 - Sara Rega, Centro Cardiologico Monzino IRCCS, Italy
Patient-derived decellularized aortas are a novel advanced 3D in vitro platform for the study of aortopathies

A4 - Jonathan Lambert, University of Padova, Italy
Defining metabolically dependent protein interactomes of Opa1 in cardiac mitochondria using a novel Opa1-TurboID transgenic mouse model

A5 - Ravi Kumar, King's College London, United Kingdom
Improving the physiological relevance of hIPSC-CM with human-serum mimetic culture media

Session Chairs: 
Nina Kaludercic, University of Padova, Italy
Ines Falcao-Pires, University of Porto, Portugal 

Judging panel: 
Monika Gladka, University Medical Center Amsterdam, The Netherlands 
Llewelyn Roderick, KULeuven, Belgium 
Christoph Maack, University Clinic Würzburg, Germany
Sveva Bollini,University of Genova, Italy
Manuel Mayr, Imperial College, London, UK
10:30 - 11:00Refreshment Break - Foyers of Teaching and Learning Building 
Lecture Theatre 1 - Teaching and Learning Building
Lecture Theatre 2 - Teaching and Learning Building 
G15 - Muirhead Tower
11:00 - 12:30                                                     Session 22 - New AI and Tools to Explore Cardiac Diseases (JMCC sponsored session

Invited Speakers:
(20 minutes each)

Christoph Dieterich, 
University Hospital Heidelberg, Germany 

How AI & bioinformatics can help in cardiovascular research


Jeff Saucerman, 
University of Virginia, USA
Logic-based machine learning to predict how drugs affect cardiomyocyte hypertrophy

Xin Zhou,
University of Oxford, UK
Computational cardiac imaging and the UK Biobank


Selected Abstracts:
(15 minutes each)

O43 - Helen Maddock, 
Coventry University, UK 
Predictive Outcome Of A Blinded Cardiovascular Pre-clinical Screening Evaluation
(In-silico and In-vitro) for Use as a Cardiovascular Safety Triage For Drug Discovery

O44 - Izzatullo Sobitov, 
Georg-August University Göttingen, Germany

Distinct Functional Signatures in Atrial and Ventricular HumaniPSC-derived Cardiomyocytes Revealed by
 High-Throughput Assays

Session Chair:
Christopher O'Shea, 
University of Birmingham

Larissa Fabritz, 
University Center of Cardiovascular Sciences UCCS, UHZ, UKE, Germany
Session 23 - Lipids Signalling in Cardiac Metabolism and Cardiac Failure

Invited Speakers:
(20 minutes each)

Frederic Boal,
Inserm/UPS UMR 1297, Université de Toulouse, France 

Phosphoinositides, PIKfyve, lysosomal function and cardiac metabolism

Alice Marino, 
UCLouvain, Belgium
Lipid signalling in heart failure: unlocking the role of myo-inositol/SMIT1 axis

Claudio Mauro, 
University of Birmingham, UK

Understanding the memory of obesity in the adaptive immune response

Selected Abstracts:
(15 minutes each)

O45 - Xin Hu, 
University of Amsterdam, Netherlands

Exogenous lactate/pyruvate
reduces the hypertrophic driver aspartate through reducing
carbohydrate oxidation and  pyruvate carboxylation in the ex vivo heart

O46 - Kaitlyn Dennis, 
University of Oxford, UK

The influence of dietary fat composition on hepatic fat metabolism: findings from in vivo human and in vitro cellular models


Session Chairs:
Katja Gehmlich, University of Birmingham, UK

Christoph Maack, 
University Hospital Würzburg, Germany
Session 24 - Therapeutic Targeting to Enhance Cardioprotection

Invited Speakers:
(20 minutes each)

Ludovic Gomez, 
Université Claude Bernard Lyon-1, France
Serine 663 phosphorylation of SERCA2 in cardiac disease

Xiaoqiu Tan, 
Southwest Medical University, China
Targeting pak2 as a novel therapy for cardiac diseases

Jolanda van der Velden, 
Amsterdam University Medical Center, Netherlands 

Targeting diastolic dysfunction via sarcomeres and microtubuli

Selected Abstracts:

(15 minutes each)

O47 - Ying-Chi Chao, 
University of Oxford, UK

Targeting Troponin I Phosphorylation for Precision Treatment of Diastolic Dysfunction



O48 - Isotta Chimenti, 
Sapienza Università Di Roma, Italy

Photo-thermal activation–induced killing of gold nanorod–loaded human cardiac fibroblasts

Session Chairs:
Sean Davidson, 
University College London, UK 

Jonathan Townend, 
University of Birmingham, UK
12:30 - 13:15 Plenary Session 5 - Lecture Theatre 1 
ES-Awards - Poster and Young Investigator awards

Session Chairs: 
Sean Davidson, University College London, UK 
Frank Lezoualch, Inserm, Toulouse University, France
Nina Kaludercic, University of Padova, Italy
Davor Pavlovic, University of Birmingham, UK 
13:15 - 14:30   Lunch - Foyers of Teaching and Learning  Building
From 14:30Departure

As part of the organisation of this conference, The University of Birmingham's Event Management Team is collecting income via registration fees and sponsorships on behalf of theInternational Society for Heart Research, European Section (ISHR-ES)

Accessibility Statement